𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency

✍ Scribed by Gillian L. McNab; Timothy R. Dafforn; Alice Wood; Elizabeth Sapey; Robert A. Stockley


Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
532 KB
Volume
23
Category
Article
ISSN
0938-8990

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Molecular pathogenesis of alpha-1-antitr
✍ David H. Perlmutter; Jeffrey L. Brodsky; William F. Balistreri; Bruce C. Trapnel πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 321 KB

In recent years, we have witnessed several important paradigm shifts in understanding the molecular basis of liver disease in alpha-1-antitrypsin (AT) deficiency. These shifts have become possible as a result of a number of advances in research on the cell biology of aggregation-prone mutant protein

Alpha-1-antitrypsin deficiency: A new pa
✍ David A. Rudnick; David H. Perlmutter πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 867 KB

Liver disease in alpha-1-antitrypsin (alpha1AT) deficiency is caused by a gain-of-toxic function mechanism engendered by the accumulation of a mutant glycoprotein in the endoplasmic reticulum (ER). The extraordinary degree of variation in phenotypical expression of this liver disease is believed to

Alpha-1-antitrypsin mutant Z protein con
✍ Douglas Lindblad; Keith Blomenkamp; Jeffrey Teckman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 671 KB

Alpha-1-antitrypsin (a1AT) deficiency is caused by homozygosity for the a1AT mutant Z gene and occurs in 1 in 2000 births. The Z mutation confers an abnormal conformation on the protein, resulting in an accumulation within the endoplasmic reticulum of hepatocytes rather than appropriate secretion. T